Gene therapy for alpha-1 antitrypsin deficiency. - sprookjes - yvandenbroek - TriplyDB

Gene therapy for alpha-1 antitrypsin deficiency.

Gene therapy for alpha-1 antitrypsin deficiency.

http://www.wikidata.org/entity/Q37866000

about

Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency Alpha-1-antitrypsin deficiency Expanding the clinical indications for α(1)-antitrypsin therapy Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy Barriers to inhaled gene therapy of obstructive lung diseases: A review Parameters Affecting Image-guided, Hydrodynamic Gene Delivery to Swine Liver.The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting A review of augmentation therapy for alpha-1 antitrypsin deficiency.Diagnosis and early detection of COPD using spirometry A novel surgical approach for intratracheal administration of bioactive agents in a fetal mouse model CpG-depleted adeno-associated virus vectors evade immune detection.A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo.The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis.Pathophysiology of Alpha-1 Antitrypsin Lung Disease.Gene correction in patient-specific iPSCs for therapy development and disease modeling.Thermal Stability as a Determinant of AAV Serotype Identity.Early recognition of alpha-1 antitrypsin deficiency and considerations for liver transplantation.RNAi in Respiratory Diseases

P2860

Q24619820-018B0DDF-CB16-4884-81FA-4130BF3D44E0 Q26995192-39FDD58C-4757-49D6-80E2-DF3CE442C0E2 Q27000764-4D1F9CA9-4117-4648-8E69-375A174F5A2A Q28080450-FE4F30AA-45DF-4B83-9F01-21B220141B8F Q29248141-B88A90FB-19A2-49D2-BB27-9944EA58AC72 Q33635920-8CD5669C-C03E-4BF3-88FB-A5642AFE4BFF Q33983876-CB20D884-AD20-457A-8F7E-8D89F3B628E4 Q34268108-7E15A451-7890-43BF-A0FF-B6949804CFD7 Q34628631-B1C25920-54A8-4E0E-B42A-51EBFD44DBC8 Q36402041-ABD3277F-2654-465B-9A44-C5A6D6433982 Q36966955-2055F3A1-7110-4C8E-BE55-AC8B35B25190 Q37031613-9A741EA4-2C18-42D2-BAEC-20D38245FAD8 Q37362027-44719FAD-D399-468C-A5F0-C7D926B810DE Q38650545-054DAA92-800D-45AB-872A-A9119F05CE48 Q38852141-19E24F21-CADE-469F-A549-FF64F6DE18E1 Q40075770-F0AED13C-EC8B-4406-A6C6-8DF89D07EB27 Q42573650-A6F7F123-37B9-48A5-9E4C-B93D77B33885 Q58061971-D7624369-F7E4-4CD1-9319-42CB0B9F6045

P2860

Gene therapy for alpha-1 antitrypsin deficiency.

http://www.wikidata.org/entity/Q37866000

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Gene therapy for alpha-1 antitrypsin deficiency.

@en

Gene therapy for alpha-1 antitrypsin deficiency.

@nl

type

label

Gene therapy for alpha-1 antitrypsin deficiency.

@en

Gene therapy for alpha-1 antitrypsin deficiency.

@nl

prefLabel

Gene therapy for alpha-1 antitrypsin deficiency.

@en

Gene therapy for alpha-1 antitrypsin deficiency.

@nl

P1433

Q37866000-97E0B93C-4910-415D-ABFC-C1E8B36E7312

P1476

Q37866000-3370881E-D545-4E24-8542-273839A1F179

P2093

Q37866000-A3740565-4D17-4EBE-BD9D-CECBCF30D5E9

Q37866000-E23DB3CA-8634-431F-B50F-DBF3352A2D28

P2860

Q37866000-007D0C26-2D97-4CFF-A83E-2CC578633C89

Q37866000-33DF2730-6B0C-418A-B1B7-DE87658BEF25

Q37866000-43AF847F-A776-4BA9-9D96-28A80524872C

Q37866000-45669AF5-D38C-4F4A-A38F-E97D2B9D621E

Q37866000-4EB642BC-C578-4D73-BDA0-F7896079E033

Q37866000-500B7D71-8FBF-4A10-B58F-7E48FBA7E214

Q37866000-592CC6FE-7C53-40EB-968C-FECADEEA5E74

Q37866000-643F8EA1-4617-463D-8C4D-37FC44EF6FA2

Q37866000-95696057-ED6E-4861-A7F2-39641BF6849F

Q37866000-9C2880DA-7168-4F2E-805B-92B2046A03E6

P304

Q37866000-B385A0A0-29F3-4BE5-861F-DA3F4869B268

P31

Q37866000-031A979D-929A-4C9F-A679-01011944ED3F

P356

Q37866000-C3208306-A8E3-41C5-B66B-F8A902A30BE9

P433

Q37866000-F195E264-ECAE-4C42-9902-9AFEA431AECE

P478

Q37866000-64A60856-F02F-47FC-9845-5BE6361518EB

P577

Q37866000-D985AEB0-87AC-4CAB-9DFF-5A3202C2BAA8

P5875

Q37866000-90BE5EFC-EA08-41DB-8DDF-B070696C77F7

P698

Q37866000-58FCC315-1579-4D94-8601-7C6082EA425F

P921

Q37866000-42E8B89A-9757-4EA0-AEC4-6A3DCB6E1527

P932

Q37866000-E4FED4B7-C9C8-47DC-9513-6290E7008038

P356

P1433

Human Molecular Genetics

P1476

Gene therapy for alpha-1 antitrypsin deficiency.

@en

P2093

Christian Mueller

http://www.w3.org/2001/XMLSchema#string

Terence R Flotte

http://www.w3.org/2001/XMLSchema#string

P2860

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

A 2.6 A structure of a serpin polymer and implications for conformational disease

Crystal structure of an uncleaved alpha 1-antitrypsin reveals the conformation of its inhibitory reactive loop

The pros and cons of immunomodulatory IL-10 gene therapy with recombinant AAV in a Cftr-/- -dependent allergy mouse model.

Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder.

Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways.

Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi.

Adeno-associated virus vectors for short hairpin RNA expression.

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors

P304

R87-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDR156

http://www.w3.org/2001/XMLSchema#string

P433

R1

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51056731

http://www.w3.org/2001/XMLSchema#string

P698

21498872

http://www.w3.org/2001/XMLSchema#string

P921

P932

3095063

http://www.w3.org/2001/XMLSchema#string